February 8th 2024
Phase 3 study reveals exebacase combined with standard antibiotics in treating methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and endocarditis did not meet its primary endpoints.
May 20th 2021
Rates of in-hospital mortality and days with bacteremia were similar between the two study cohorts.
June 11th 2020
The antibacterial is efficacious in a majority of patients in a small study.
February 19th 2020
The MRSA infection investigation was halted by the data and safety monitoring board due to concerns over acute kidney injury.
February 14th 2020
Therapy options have increased in recent decades, yet there is a lack of guidance.
Standard Protocol for the Treatment of ABSSSI
Lipoglycopeptide Antibiotics for ABSSSI: Education
OPAT Protocols: Navigating Challenges
Establishing Real-World Protocols for OPAT
Trends of ABSSSI Incidence in the Community
ABSSSI Case Scenarios for OPAT
Gram-Positive ABSSSI: Early Identification and Follow-Up
Lipoglycopeptide Therapies for Gram-Positive Infections
Determining the Severity of ABSSSI
ABSSSI: Outpatient Parenteral Antibiotic Therapy
Treatment of ABSSSI: Inpatient Versus Outpatient
Oral Antibiotic Compliance for ABSSSI
Cost Considerations of IV Antibiotics for ABSSSI
ABSSSI: Standard Protocol of Admission and Treatment
Understanding the Prevalence of ABSSSI in the Community
An Overview of ABSSSI
ASM Microbe 2018 Opening Session: From Basic to "Frugal" Science
The opening session of ASM Microbe 2018 cuts a broad swath through the science of microbiology.
The Ugly Reality of Privacy Curtains
A new study gives strong reasons to back implementing cleaning strategies for hospital privacy curtains.
Contact Precautions for Endemic Pathogens: Is There A Paradigm Shift in the Making?
Dr. Gonzalo Bearman delves into the use of contact precautions for endemic pathogens such as MRSA and VRE and assesses the effectiveness of this approach.
Positive Clinical Responses Reported for VIBATIV in Obese & Elderly Patients with cSSSIs
Researchers present positive new data from multiple studies of VIBATIV at the 2018 ECCMID conference in Madrid, Spain.
Top 5 Infectious Disease News of the Week—April 15, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Long-Acting Anti-MRSA Agents: One Dose to Cure?
A review of the current literature and future directions.
Meta-Analysis On the Utility of Nasal Swabs to Rule Out MRSA Pneumonia
Many patients with pneumonia are empirically treated with anti-MRSA therapy, leaving antimicrobial stewardship programs faced with the challenge of identifying patients who truly warrant continuation of this therapy.
New Synthetic Antibiotics May Combat MRSA and Other Superbugs
Antibiotic resistance is highly concerning to researchers, but a team of researchers have identified new synthetic antibiotics with the potential to kill aggressive bacteria.
Clinical Outcomes of Vancomycin Mono or Combination Therapy with a Beta-Lactam Against MRSA Bacteremia
Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with high mortality.
WHO's New Surveillance System Finds High Levels of Antibiotic Resistance Worldwide
The World Health Organization (WHO) released its first report on antibiotic resistance surveillance data.
eNose Successfully Recognizes Bacteria in Common Soft Tissue Infections
The eNose was also able to recognize methicillin-resistant Staphylococcus aureus (MRSA) from methicillin-sensitive Staphylococcus aureus (MSSA).
Impact of MRSA on Lymphatic Function Studied by MGH Investigators
Investigators from Massachusetts General Hospital (MGH) have made some interesting findings about methicillin-resistant Staphylococcus aureu (MRSA) that may hold the key to curbing lymphatic repercussions.
SHEA Releases Guidance on Duration of Contact Precautions for MDR Infections
SHEA has released expert guidance advising hospitals on when they can safely take patients with multidrug-resistant bacteria off of contact precautions.
Challenges to Disinfecting Hospital Rooms to Prevent C. difficile—Part 2
Maureen Spencer, Accelerate Diagnostics, sat down with Contagion® to discuss the challenges of disinfecting hospital rooms to prevent C. difficile.
2 Commerce Drive Cranbury, NJ 08512